Glaukos Corporation recently reported a new study recently published in the Journal of Glaucoma showed a single iStent® Trabecular Micro-Bypass Stent significantly reduced intraocular pressure (IOP) when implanted as a standalone procedure in pseudophakic eyes with open-angle glaucoma.
For the study, researchers from the University of South Dakota Sanford School of Medicine and Vance Thomson Vision reportedly evaluated iStent procedure outcomes in 42 pseudophakic eyes with preoperative mean IOP of 20.26 mm Hg.
According to researchers, mean medicated IOP decreased 6.64 mm Hg to 13.62 mm Hg, or 33 percent, in 21 eyes after two years. And in total, 96 percent of study patients with preoperative medicated IOP ≥ 19 mm Hg achieved an IOP reduction at their last collected follow-up.
Click here to read the study in the Journal of Glaucoma.
Click here to read the full press release.
Source: Glaukos Corporation